TD2 collaborates with local and national world-class entities, including

Horizon Discovery is a translational genomics and personalized medicine company founded in June 2007 and is headquartered at IQ Cambridge, Cambridge, U.K., and with additional research laboratories in Torino, Italy. Horizon's goal is to convert new information on the genetic causes of cancer into laboratory models that will facilitate the discovery of drugs that target these defects.



Scottsdale Health Care



Study Log provides animal study management solutions to commercial and academic research organizations. Studylog enables organizations to efficiently manage study conduct and study data within a searchable and accessible framework. Organizations can now centrally store and index the institutional knowledge that usually resides in notebooks and the memories of individual researchers.

The Translational Genomics Research Institute (TGen) is a non-profit 501(c)(3) organization focused on developing earlier diagnostics and smarter treatments. TGen is on the cutting edge of translational research where investigators are able to unravel the genetic components of common and complex diseases. Working with collaborators in the scientific and medical communities, TGen believes it can make a substantial contribution to the efficiency and effectiveness of the translational process.